Edwards Lifesciences Corporation to Present at the Goldman, Sachs & Co. and William Blair Conferences

IRVINE, CA--(Marketwired - June 04, 2013) -

Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, is scheduled to present at two upcoming conferences on Tuesday, June 11, 2013. Thomas M. Abate, Edwards’ corporate vice president and chief financial officer, is scheduled to speak to attendees of the Goldman Sachs 34th Annual Global Healthcare Conference at the Terranea Resort in Rancho Palos Verdes, California at 8:00 a.m. PDT. That same day, Donald E. Bobo, Edwards’ corporate vice president, heart valve therapy, is scheduled to speak at the William Blair 33rd Annual Growth Stock Conference at the Four Seasons Hotel in Chicago, Illinois at 2:50 p.m. CDT.

Live webcasts of both presentations will be available to all interested parties on the Edwards Lifesciences investor relations website at http://ir.edwards.com. Following each presentation, an archived version of the webcast will be available on the Edwards investor relations website in the News and Events section and via the Edwards Lifesciences Investor Relations App for mobile devices.

About Edwards Lifesciences

Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring. Driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring that enable them to save and enhance lives. Additional company information can be found at www.edwards.com.

Edwards, Edwards Lifesciences, and the stylized E logo are trademarks of Edwards Lifesciences Corporation.